Cancer Keys: The two tests that will diagnose at least 90% of myeloma patients

New tool for GPs to tackle late cancer diagnosis

Latest articles: New tool for GPs to tackle late cancer diagnosisThursday 18 July 2019A new patient-recommended tool for GPs is being launched across England in a bid to catch cancers sooner.Known as GatewayC, the innovative online training tool has already shown...

read more

Cancer Keys: Prostate cancer and nocturia

Latest articles: Welcome to Cancer Keys, a regular bite-sized learning column brought to you by GatewayC in collaboration with Cancer Research UK. Prostate cancer and nocturiaMany men with early prostate cancer don’t have any obvious signs or symptoms. However, early...

read more

Welcome to Cancer Keys, a regular bite-sized learning column brought to you by GatewayC in collaboration with Cancer Research UK.

 

Myeloma investigations

If you are suspicious of myeloma following blood results, there are two pertinent investigations that can be ordered in primary care to give a strong case for referral:

1. Serum protein electrophoresis test
2. Bence-Jones protein urine test

Potential Pitfall

If you test for serum protein electrophoresis alone, you will identify only 2/3 of patients.

Helpful hint

Most patients with untreated myeloma have a monoclonal immunoglobulin peak in serum, urine, or both. A combination of serum protein electrophoresis and Bence-Jones protein urine test will diagnose up to 95% of patients with myeloma without any form of imaging. NICE NG12 guidelines suggest making a suspected cancer referral for patients whose investigation results indicate myeloma.

 

Cancer Keys are a collaboration between GatewayC and Cancer Research UK. Visit GatewayC’s Myeloma – Early Diagnosis course here.

 

LinkedIn Twitter Facebook